Skip to main content
. 2020 Aug 6;105(9):e3355–e3362. doi: 10.1210/clinem/dgaa411

Figure 1.

Figure 1.

Cholesterol efflux capacity (CEC) during hypothyroidism (Hypo) and during thyroid hormone supplementation (THS) in 17 patients with differentiated thyroid carcinoma. The median, interquartile range, and total range are shown as boxplots. (A) CEC (AU), (B) CEC after correction for high density lipoprotein cholesterol (HDL-C), (C) CEC after correction for HDL particle (HDL-P) concentration.